Combination treatment of child and adolescent anxiety disorders

Phase 4

• Conditions: Anxiety; Mental Health - Anxiety

• Registration Number: ACTRN12613001059752
• Lead Sponsor: Professor Jennifer Hudson

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-09-23
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Primary anxiety diagnosis

Exclusion Criteria

1.Are receiving concurrent pharmacological therapy (other than a stable dose of stimulant medication for ADHD) – especially should not be taking pimozide [for vocal/motor tics] or anti-inflammatory medications.
2.Are receiving concurrent psychological treatment
3.Current MDD, suicidal and/or are self harming.
4.Considered at-risk due to abuse, neglect or extended school refusal
5.Significant learning delays that prevent mainstream class placement (intellectual disabilities).
6.Autism or related disorders (developmental disorders)
7.Eating disorder
8.Substance Use Disorder
9.History of bipolar disorder
10.Psychotic symptoms
11.Participants with a history or current heart, kidney, liver issues, diabetes, glaucoma or epilepsy.
12.Are pregnant
13.Inpatient

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Remission of primary anxiety diagnosis assessed via the ADIS-IV C/P[Post-Treatment and 6 month follow-up];Remission of any anxiety diagnosis assessed via the ADIS-IV C/P[Post-Treatment and 6 month follow-up]